 "Pharmaceutical tablets and capsules")
Orchid Pharma has posted a net loss of Rs 166.27 crore during the quarter ended June 30, 2016, as compared to a net loss of Rs 47.56 crore registered in the same period of last financial year.
The total income from operations stood at Rs 190.91 crore during the quarter, as against Rs 256.33 crore during the same quarter last year.
"The reduced turnover is on account of product mix and capacity utilisation," said K Raghavendra Rao, managing director, Orchid Pharma. However, the proposed launch of new products during the current financial year, the company is confident of improving the volumes and profitability in the ensuing quarter, he added.
